Behera, G.B. et al., “Quaternization of Thiazoles,” J. Org. Chem. 38:2164-2166, American Chemical Society (1973). |
Joshi, K.C. and Giri, S. “Organic Pesticides. Part IX. Synthesis of some 2-Arylamino-4-substituted Phenylthiazoles and their Acetoxy-mercuri Derivatives,” Jour. Indian Chem. Soc. 39:18-19, Indian Chemical Society (1962). |
Joshi, K.C. et al., “Synthesis of Some New Fluorine Containing 2-(N-Arylamino)/2-methyl-4-aryl Thiazoles and Their Bacterial Activity,” Agric. Biol. Chem. 43:199-201, Nippon Nogei Kagakkai (1979). |
Khadse, B.G. et al., “Synthesis of 4-Aryl-& 4-Heteroaryl-2-(substituted-phenylamino)thiazoles as Antitubercular Agents,” Ind. J. Chem. 20B:683-685, Council of Scientific & Industrial Research (1981). |
Khan, R.H. and Bahel, S.C., “Synthesis of Fluoroarylthiazoles and Related Compounds as Possible Fungicides,” Agr. Biol. Chem. 40:1129-1135, Nippon Nogei Kagakkai (1976). |
Mahapatra, G.N. and Rout, M.K., “Preparation of N-Substituted 2-Aminothiazoles. Part 1. Condensation of Acetophenone with Substituted Thioureas,” Jour. Indian Chem. Soc. 30:398-400, Indian Chemical Society (1953). |
Modi, J.D. et al., “Potential Anticancer Agents. Nitrogen Mustards of Aminophenylthiazoles,” J. Med. Chem. 14:887-888, American Chemical Society (1971). |
Olin, J.F. and Johnson, T.B., “Synthesis of 4-Phenylthiazole-2-Methanol and Some of its Derivatives. VIII.,” J. Amer. Chem. Soc. 53:1471-1472, American Chemical Society (1931). |
Reddy-Sastry, C.V. et al., “Synthesis & Biological Activity of Some New 6-Isothiocyanato-, 6-N-[N,N-Bis(methoxycarbonyl)guanidino]-, & 6-(Aryl/2-arylaminothiazol-4-yl)-2H-1,4-benzoxazin-3(4H)-ones,” Ind. J. Chem. 26B: 662-665, Council of Scientific & Industrial Research (1987). |
Rinde, S.S. et al., “Synthesis of Some Thiazole Substituted Phenylamino-4-thiazolidinones,” J. Ind. Chem. Soc. 62:334-335, Indian Chemical Society (1985). |
Sabnis, S.S., “Synthesis of Potential Anticancer Agents Derived from Benzaldehyde Nitrogen Mustard & Aminophenylthiazoles,” Ind. J. Chem. 5:619-621, Council of Scientific & Industrial Research (1967). |
Seligman, R.B. et al., “Some Derivatives of p-Aminosalicyclic Acid,” J. Amer. Chem. Soc. 75:6334-6335, American Chemical Society (1953). |
Sharma, G.M. et al., “Thiopegan Derivatives-XXI. A Mechanism for the Formation of 9:10 and 10:11 Thiopegan Derivatives,” Tetrahedron 15:53-59, Pergamon Press Ltd. (1961). |
Shingare, M.S. and Ingle, D.B., “Synthesis of Some Sulfonamide Derivatives,” J. Ind. Chem. Soc. 54:705-708, Indian Chemical Society (1977). |
Singh, J.M., “Studies of the chemistry of azole derivatives. IV. New N-substituted 2-aminothiazoles,” Can. J. Chem. 46:1168-1169, NRC Research Press (1968). |
International Search Report for International Application No. PCT/US01/10307. |
Joshi, K.C. et al., “Synthesis of Some New Fluorine Containing 2-(N-Arylamino)/2-methyl-4-aryl Thiazoles and Their Bacterial Activity,” Agric. Biol. Chem. 43:199-201, Agricultural Chemical Society of Japan (1979). |
Khan, R.H. and Bahel, S.C., “Synthesis of Fluoroarylthiazoles and Related Compunds as Possible Fungicides,” Agr. Biol. Chem. 40:1129-1135, Agricultural Chemical Society of Japan (1976). |
Manian, A.K. et al., “Synthesis of 2-Substituted-Anilino/Phenyl/Benzyl-5-Substituted-4-Phenylamido-(3-o-Chlorophenyl-5-Methylisoxazolyl) Thiazoles as Potential Antitubercular and Antimicrobial Agents,” Indian Drugs 31:442-444, Indian Drug Manufacturers' Association (1994). |
Metri, J. et al., “Synthesis of New Sulphamylanilino Substituted Thiazoles of Potential Biological Activity,” Egypt. J. Chem. 25:187-189, National Information and Documentation Centre, NIDOC Dokki (1982). |
Nath, J.P. et al., “Synthesis & Halogenation of Some New 2-(o-Mercaptophenyl) amino-4-substituted-thiazoles & Oxazoles as Pesticides,” Indian J. Chem. 18B:384-386, Council of Scientific and Industrial Research (1979). |
Panigrahi, A.K. et al., “Arsenic Derivatives of Thiazoles,” J. Inst. Chemists (India) 42:17-21, Organon (India) Ltd. (1970). |
Pathak, R.B. et al., “Synthesis of Some Fluoroarylthiazoles and Related Compounds as Potential Fungicides,” J. Antibact. Antifung. Agents 9: 477-480, Research Society for Antibacterial and Antifungal Agents, Japan (1981). |
Pathak, V.N. and Singh, R.P., “Synthesis and Biological Activities of Some New 2-(N-Arylamino)-4-(Fluoroaryl) thiazoles,” J. Indian Chem. Soc. 56:1010-1012, Indian Chemical Society (1979). |
Patil, V.H. and Ingle, D.B., “2-Aryl amino-4-′4′(benzene sulphonamido)-phenyl-thiazoles,” J. Indian Chem. Soc. 59:1000-1003, Indian Chemical Society (1982). |
Rindhe, S.S. et al., “Synthesis of Some Thiazole Substituted Phenylimino-4-thiazolidinones,” J. Indian Chem. Soc. 62:334-335, Indian Chemical Society (1985). |
Sawhney, S.N. et al., “Synthesis and Anti-inflammatory Activity of 2-Amino- & 2-Alkylamino-6-benzothiazoleacetic Acids, 4-(2′-Benzothiazolylamino)-, 4-(4′-Substituted-2-thiazolylamino)-& 4-(4′-Substituted-3-alkyl-Δ4′thiazoline-2′-(imino)-phenylacetic Acids,” Indian J. Chem. 16B:605-609, Council of Scientific and Industrial Research (1978). |
Singh, H. et al., “Thiopegan Derivatives: Part XXXIV—Reactions of Ethyl Anthranilate Thiocyanate,” Indian. J. Chem. 7:571-574, Council of Scientific and Industrial Research (1969). |
Singh, S.P. et al., “TLC Separation of Some Isomeric 2- and 6-[2-Amino (and substituted amino)-4-thiazolyl] Benzothiazoles,” Fres. Z. Anal. Chem. 288:285, Springer-Verlag (1977). |
Singl, S.P. et al., “Studies in Hantzsch thiazole synthesis: Part 2—Reactions of thiocarboxamides with α-haloketones,” Indian J. Chem. 29B:533-538, Publications and Information Directorate, CSIR (1990). |
Thakar, K.A. et al., “Synthesis of 2-(Substituted Anilino) 4-(Substituted Phenyl) thiazoles,” J. Pharm. Sci. 67:587-589, American Pharmaceutical Association (1978). |
STN Easy Abstract for Document AT11, Accession No. 1984:630402 CAPLUS, <<http://stneasy.cas.org/tmp/27038-1842628305-200/727859240.html>>. |
Bajou, K., et al., “Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization,” Nat. Med. 4:923-928, Nature America (1998). |
Björquist, P., et al., “Identification of the Binding Site for a Low-Molecular-Weight Inhibitor of Plasminogen Activator Inhibitor Type 1 by Site-Directed Mutagenesis,” Biochem. 37:1227-1234, American Chemical Society (1998). |
Charlton, P., et al., “XR5118, a novel modulator of plasminogen activator inhibitor-1 (PAI-1), increases endogenous tPA activity in the rat,” Fibrinol. Proteol. 11:51-56, Pearson Professional Ltd. (1997). |
Charlton, P.A., et al., “Evaluation of a Low Molecular Weight Modulator of Human Plasminogen Activator Inhibitor-1 Activity,” Thromb. Haemo. 75:808-815, Schattauer GmbH (1996). |
Friederich, P.W., et al., “Novel Low-Molecular-Weight Inhibitor of PAI-1 (XR5118) Promotes Endogenous Fibrinolysis and Reduces Postthrombolysis Thrombus Growth in Rabbits,” Circ. 96:916-921, American Heart Association, Inc. (1997). |
Kluft, C., et al., “The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma,” Scand. J. Clin. Lab. Invest. 45:605-610, Blackwell Scientific Publisher (1985). |
Kruithof, E.K.O., et al., “Plasminogen Activator Inhibitor 1: Development of a Radioimmunoassay and Observations on Its Plasma Concentration During Venous Occlusion and After Platelet Aggregation,” Blood 70:1645-1653, Grune and Stratton, Inc. (1987). |
Lawrence, D.A., et al., “Localization of Vitronectin Binding Domain in Plasminogen Activator Inhibitor-1,” J. Biol. Chem. 269:15223-15228, American Society for Biochemistry and Molecular Biology, Inc.(1994). |
Liu, G., et al., “Co-expression of Urokinase, Urokinase Receptor and PAI-1 is Necessary for Optimum Invasiveness of Cultured Lung Cancer Cells,” Int. J. Cancer 60:501-506, Wiley-Liss, Inc. (1995). |
Lundgren, C.H., et al., “Elaboration of Type-1 Plasminogen Activator Inhibitor From Adipocytes: A Potential Pathogenetic Link between Obesity and Cardiovascular Disease,” Circ. 93:106-110, American Heart Association, Inc. (1996). |
Lupu, F., et al., “Localization and Production of Plasminogen Activator Inhibitor-1 in Human Healthy and Atherosclerotic Arteries,” Arterio. Thromb. 13:1090-1100, American Heart Association, Inc. (1993). |
Padró, T., et al., “Quantification of Plasminogen Activators and Their Inhibitors in Aortic Vessel Wall in Relation to the Presence and Severity of Atherosclerotic Disease,” Arterio. Thromb. Vasc. Biol. 15:893-902, American Heart Association, Inc. (1995). |
Patrassi, G.M., et al., “Familial Thrombophila Associated with High Levels of Plasminogen Activator Inhibitor,” Fibrinolysis 6:99-103, Longman Group U.K. Ltd. (1992). |
Sawa, H., et al., “Potentiation by Hypercholesterolemia of the Induction of Aortic Intramural Synthesis of Plasminogen Activator Inhibitor Type 1 by Endothelial Injury,” Circ. Res. 73:671-680, American Heart Association, Inc. (1993). |
Sobel, B. E. et al., “Increased Plasminogen Activator Inhibitor Type 1 in Coronary Artery Atherectomy Specimnes From Type 2 Diabetic Compared With Nondiabetic Patients: A Potential Factor Predisposing to Thrombosis and Its Persistence,” Circ. 97:2213-2221, American Heart Association, Inc. (1998). |
Tsuchiya, H., et al., “The Antibody to Plasminogen Activator Inhibitor-1 Suppresses Pulmonary Metastases of Human Fibrosarcoma in Athymic Mice,” Gen. Diag. Pathol. 141:41-48, Gustav Fischer (1995). |
Dialog File 351, Accession No. 2567225, Derwent WPI English language abstract for JP 55133366 (Document AL1). |
Dialog File 351, Accession No. 7183583, Derwent WPI English language abstract for JP 62108859 A2 (Document AM1). |
Dialog file 351, Accession No. 7268328, Derwent WPI English language abstract for EP 0 237 929 B1 (Document AN1). |
Dialog file 351, Accession No. 9802848, Derwent WPI English language abstract for WO 94/01423 (Document AP1). |